HQD could improve the mitochondrial function of rats with PD by upregulating the expression of glucose transporter GLUT1, the level of HK, and the content of tricarboxylic acid cycle rate-limiting enzyme CS to reactivate the aerobic glycolysis pathway. Here, SLC2A1 is linked to Parkinson disease.